2026-05-13T11:33:39-05:00 2025-12-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2025-01-01 131949477 NEW YORK BLOOD CENTER INC NEWY 2125703000 601 MIDLAND AVE RYE NY 10580 DAVID BENCH CHIEF FINANCIAL OFFICER 2125703100 2026-05-13 1 LAURA J KENNEY P00202198 6177170831 2026-05-04 2025 2025-03-06 01:10:19Z DR CHRISTOPHER D HILLYER 601 MIDLAND AVE RYE NY 10580 734783426 0 X NYBC.ORG X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION.SPECIFICALLY, NYBC EXISTS:- TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS.- TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH- TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT- TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS 17 16 3420 750 0 0 15901132 15448313 582247663 599819144 4911840 11087554 2710329 2684341 605770964 629039352 255427 256669 0 0 267607598 263635842 0 0 522279 384874206 399514816 652737231 663407327 -46966267 -34367975 884660660 865370158 329176524 303993196 555484136 561376962 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C. 0 0 309791313 256669 407722231 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS,TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TOHOSPITALS IN THE REGIONS SERVED BY NYBCE DIVISIONS. 176730524 192096913 MEDICAL PROGRAMS: (1) HEMOPHILIA SERVICES CONSORTIUM,(2) COMPREHENSIVE CELL SOLUTIONS (INCLUDES APHERESIS/TRANSFUSION SERVICES AND CONTRACT MANUFACTURING), (3) BONE MARROW PROGRAM, AND (4) NATIONAL CORD BLOOD PROGRAM (COLLECTION, PROCESSING, AND STORAGE OF CORD BLOOD UNITS AND DISTRIBUTION OF THESE UNITS FOR TREATMENT OR RESEARCH PURPOSES) 12480327 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES AWIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD ANDBLOOD RELATED DISEASES. 499002164 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 0 0 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 1 X 300 0 1 3420 1 1 0 0 0 0 0 0 0 0 0 0 1 0 X 17 16 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL MA MD MI MN NC NJ NY PA RI TN VA WI X DAVID BENCH 2125703440 601 MIDLAND AVE RYE NY 10580 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 2555660 0 122393 AVERY AUGUST TRUSTEE 1.00 X 0 0 0 JUNG CHOI TRUSTEE 1.00 X 0 0 0 YVES DENIZE TRUSTEE 1.00 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.00 X 0 0 0 PHILIP J FALIVENE TRUSTEE 1.00 X 0 0 0 JOHN FERRETTI TRUSTEE 1.00 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.00 X 0 0 0 OWEN GARRICK TRUSTEE 1.00 X 0 0 0 MARC KRAMER TRUSTEE 1.00 X 0 0 0 AARON R MARCU TRUSTEE 1.00 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.00 X 0 0 0 JOHN L ROSENTHAL TRUSTEE 1.00 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.00 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 1.00 X 0 0 0 JAIME SHAMONKI TRUSTEE 1.00 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.00 X 0 0 0 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 50.00 X 90364 0 12918 ADRIAN DAVID EVP, CHIEF OPERATING OFFICER 50.00 X 384793 0 18668 LARRY LUCHSINGER SVP, CHIEF SCIENTIFIC OFFICER 50.00 X 376901 0 48263 BRUCE SACHAIS SVP, CHIEF MEDICAL OFFICER 50.00 X 451374 0 61609 ANDREA CEFARELLI EVP, CHIEF OPERATING OFFICER 50.00 X 454288 0 44103 SHILPI BANERJEE SVP, GENERAL COUNSEL AND SECRETARY 50.00 X 419487 0 20438 RICHARD KIERNAN SVP, CHIEF HUMAN RESOURCES OFFICER 50.00 X 462125 0 60791 VAUGHN RATCHFORD SVP, CHIEF REAL ESTATE OFFICER 50.00 X 571759 0 74251 BETSY JETT SVP, QUALITY AND REGULATORY AFFAIRS 50.00 X 526442 0 47728 DAVID BENCH EVP, CHIEF FINANCIAL OFFICER 50.00 X 618470 0 90601 JOSEPH MOHR EVP, CHIEF BUSINESS OFFICER 50.00 X 884985 0 81565 DAVID GRAHAM SVP ENTERPRISE DONOR ENGAGEMENT 50.00 X 286212 0 23808 DONNA STRAUSS SVP, ENTERPRISE LABORATORY SERVICES 50.00 X 188847 0 29940 SARAH VOSSOUGHI SVP ENTERPRISE LABORATORY SERVICES 50.00 X 174143 0 25634 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 50.00 X 264139 0 29570 CLAY RICH SVP, DEPUTY COO BLOOD AND LAB OPERATIONS 50.00 X 288838 0 52550 JONATHAN BARBA VP, INFORMATION TECHNOLOGY 50.00 X 324184 0 54734 MAHTAB KHAN VICE PRESIDENT OF FINANCE 50.00 X 341090 0 48110 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 50.00 X 351905 0 70113 PATRICIA KILLEEN SVP, LOGISTICS, OPS EXCELLENCE 50.00 X 432772 0 57502 JO ANNE VALENTINO SVP COMPREHENSIVE CELL SOLUTIONS 50.00 X 359408 0 16889 MONIQUE BROWN GEORGE VP, HUMAN RESOURCES 50.00 X 333716 0 41400 ERIC GEHRIE DEPUTY CHIEF MEDICAL OFFICER 50.00 X 338107 0 46116 JEANNIE MASCOLINO VP, BLOOD OPERATIONS NYBC 50.00 X 399423 0 68817 MEGHAN WOOD VP, VENTURES & BUSINESS DEVELOPMENT 50.00 X 445797 0 74381 12325229 0 1322892 576 0 1 0 CONSIGLI CONSTRUCTION CO INC 72 SUMMER STREET MILFORD MA 01757 CONSTRUCTION SERVICES 24903648 THE WHITING-TURNER CONTRACTING COMPANY 131 CONTINENTAL DRIVE STE 404 NEWARK DE 19713 CONSTRUCTION SERVICES 3116556 INCEPT CORPORATION 4150 BELDEN VILLAGE ST CANTON OH 44718 BLOOD DONOR MARKETING 2208438 SHER DEL TRANSFER & RELOCATION 171 CENTRAL AVE HILLSIDE NJ 07205 RELOCATION SERVICES 1924763 ALL SYSTEMS MESSENGER & TRUCKING 2735 GRAND AVE BELLMORE NY 11710 COURIER SERVICES 1505973 86 10170942 5277371 615653 15448313 BLOOD SERVICES 621500 407722231 407722231 MEDICAL PROGRAMS 621500 192096913 192096913 599819144 1775847 1775847 39592 39592 400981 0 400981 400981 400981 110004000 5051781 104952020 792054 5051980 4259727 9311707 9311707 REBATES & MISCELLANEOU 2243768 2243768 2243768 629039352 602062912 0 11528127 256669 256669 15052035 1806244 13245791 67476 63636 3840 187517877 144978979 42201066 337832 18027006 16024135 1994669 8202 29790189 22993790 6748683 47716 13181259 10158486 2998130 24643 2156953 201841 1955112 266372 266372 72500 72500 2222518 2222518 22903040 8397497 14504228 1315 3388580 3223173 159907 5500 4395715 963263 3429221 3231 12172716 17910 12154806 31135 31135 22771091 57612 22713479 3329485 2742942 585750 793 182515 73812 107860 843 1859963 1859963 18210873 8147139 10031611 32123 8051729 8051729 SUPPLIES 249242168 240802980 8439113 75 R&M & EQUIPMENT 20801051 11203793 9597258 MGMT FEE-HEMOPHILIA CON 11590505 11590505 COURIER/DELIVERY SERVIC 7691319 7687694 3625 8174588 7578929 535653 60006 663407327 499002164 163882884 522279 43148 129161 30306781 41967774 4983954 95829028 107180343 33878586 32954184 5716694 5435472 419302972 200076472 201583697 219226500 817949 939285 385528382 327595882 2134677 1937630 128821718 123019973 884660660 865370158 82621893 73046900 49933729 50574941 24362273 23644220 10500000 161758629 156727135 329176524 303993196 X 548955428 553090087 6528708 8286875 555484136 561376962 884660660 865370158 -34367975 40260801 0 X 0 1 X 1 1 1 X 12767729 16625619 21586173 15901132 15448313 82328966 376487315 522931505 542547064 584071128 602062912 2628099924 389255044 539557124 564133237 599972260 617511225 2710428890 28000 43525 43500 34749 58106 207880 186892859 196996315 187206606 571095780 28000 43525 186936359 197031064 187264712 571303660 2139125230 1413224 2126061 3591559 1876434 2216420 11223698 1413224 2126061 3591559 1876434 2216420 11223698 390668268 541683185 567724796 601848694 619727645 2721652588 0.78600 0.85140 0.00410 0.00400 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 72500 72500 663334827 663407327 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 255590 402959 252000 72500 983049 250000 250000 250000 250000 1000000 1500000 16871175 16871175 210885911 55368471 155517440 122349968 97138188 25211780 69195918 47569813 21626105 219226500 INVESTMENT FUNDS 327595882 F 327595882 SECURITY DEPOSITS HELD BY LANDLORDS 418748 RIGHT OF USE ASSET 122601225 123019973 CAPITAL LEASES - RIGHT OF USE LIABILITY 156727135 156727135 X 667665479 40260801 589055 40849856 626815623 2222518 1211 2223729 629039352 661772653 589055 589055 661183598 2222518 1211 2223729 663407327 PART X, LINE 2: NYBCE HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC) AND IS GENERALLY EXEMPT FROM STATE AND LOCAL INCOME TAXES, EXCEPT ON ANY INCOME GENERATED FROM ACTIVITIES UNRELATED TO NYBCE'S EXEMPT PURPOSE. NYBCE HAS ADOPTED THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) INTERPRETATION NO. 48, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES (FIN 48). FIN 48 CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ORGANIZATION'S FINANCIAL STATEMENTS AND PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. NYBCE RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT HAS DETERMINED THERE ARE NO UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024. VENTURES IS A SINGLE MEMBER LLC AND IS TREATED AS A DISREGARDED ENTITY FOR FEDERAL INCOME TAX PURPOSES. VENTURES IS WHOLLY OWNED BY NYBCE. PART XI, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN REVENUES AND EXPENSES 1,211. PART XII, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN REVENUES AND EXPENSES 1,211. CENTRAL AMERICA AND THE CARIBBEAN INVESTMENTS 738881 0 0 0 0 0 0 738881 0 738881 0 0 1 1 1 0 1 SCHOLARSHIPS 480 256669 PART III COLLEGE SCHOLARSHIPS ARE AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X 0 0 X X X X X 1 1 0 0 0 0 0 1 0 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 1234733 0 1205000 0 115927 0 88941 0 33452 0 2678053 0 59419 0 JOSEPH MOHR EVP, CHIEF BUSINESS OFFICER 661168 0 172396 0 51421 0 48609 0 32956 0 966550 0 20911 0 DAVID BENCH EVP, CHIEF FINANCIAL OFFICER 549330 0 56650 0 12490 0 39933 0 50668 0 709071 0 0 0 VAUGHN RATCHFORD SVP, CHIEF REAL ESTATE OFFICER 421561 0 142436 0 7762 0 30288 0 43963 0 646010 0 0 0 BETSY JETT SVP, QUALITY AND REGULATORY AFFAIRS 458126 0 45971 0 22345 0 32405 0 15323 0 574170 0 8745 0 RICHARD KIERNAN SVP, CHIEF HUMAN RESOURCES OFFICER 406001 0 41200 0 14924 0 13423 0 47368 0 522916 0 0 0 MEGHAN WOOD VP, VENTURES & BUSINESS DEVELOPMENT 372682 0 72401 0 714 0 27227 0 47154 0 520178 0 0 0 BRUCE SACHAIS SVP, CHIEF MEDICAL OFFICER 379428 0 40988 0 30958 0 28892 0 32717 0 512983 0 5482 0 ANDREA CEFARELLI EVP, CHIEF OPERATING OFFICER 381865 0 37132 0 35291 0 40762 0 3341 0 498391 0 1666 0 PATRICIA KILLEEN SVP, LOGISTICS, OPS EXCELLENCE 361276 0 39147 0 32349 0 24500 0 33002 0 490274 0 3489 0 JEANNIE MASCOLINO VP, BLOOD OPERATIONS NYBC 368070 0 27970 0 3383 0 35000 0 33817 0 468240 0 0 0 SHILPI BANERJEE SVP, GENERAL COUNSEL AND SECRETARY 387307 0 0 0 32180 0 4187 0 16251 0 439925 0 0 0 LARRY LUCHSINGER SVP, CHIEF SCIENTIFIC OFFICER 326234 0 32500 0 18167 0 23129 0 25134 0 425164 0 0 0 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 324312 0 24881 0 2712 0 33995 0 36118 0 422018 0 0 0 ADRIAN DAVID EVP, CHIEF OPERATING OFFICER 215336 0 55000 0 114457 0 11407 0 7261 0 403461 0 0 0 MAHTAB KHAN VICE PRESIDENT OF FINANCE 315774 0 23809 0 1507 0 22555 0 25555 0 389200 0 0 0 ERIC GEHRIE DEPUTY CHIEF MEDICAL OFFICER 307697 0 30000 0 410 0 0 0 46116 0 384223 0 0 0 JONATHAN BARBA VP, INFORMATION TECHNOLOGY 300671 0 22941 0 572 0 21732 0 33002 0 378918 0 0 0 JO ANNE VALENTINO SVP COMPREHENSIVE CELL SOLUTIONS 335687 0 21274 0 2447 0 16889 0 0 0 376297 0 0 0 MONIQUE BROWN GEORGE VP, HUMAN RESOURCES 308435 0 23069 0 2212 0 22123 0 19277 0 375116 0 0 0 CLAY RICH SVP, DEPUTY COO BLOOD AND LAB OPERAT 267025 0 17837 0 3976 0 11975 0 40575 0 341388 0 0 0 DAVID GRAHAM SVP ENTERPRISE DONOR ENGAGEMENT 101447 0 37531 0 147234 0 10304 0 13504 0 310020 0 0 0 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 191146 0 28065 0 44928 0 9957 0 19613 0 293709 0 0 0 DONNA STRAUSS SVP, ENTERPRISE LABORATORY SERVICES 107481 0 38771 0 42595 0 14184 0 15756 0 218787 0 4984 0 SARAH VOSSOUGHI SVP ENTERPRISE LABORATORY SERVICES 151643 0 22500 0 0 0 5326 0 20308 0 199777 0 0 0 PART I, LINE 1A IN 2025, CHRISTOPHER D. HILLYER WAS PAID $2,100 FOR TAX INDEMNIFICATION RELATED TO FRINGE BENEFITS INCLUDED IN HILLYER'S TAXABLE WAGES. TAX INDEMNIFICATION PAYMENTS ARE INCLUDED IN TAXABLE WAGES. PART I, LINES 4A-B: THE FOLLOWING INDIVIDUALS RECEIVED SEVERANCE PAYMENTS IN 2025 IN ACCORDANCE WITH THEIR AGREEMENTS WITH THE ORGANIZATION: - ADRIAN DAVID - $100,000 - DAVID GRAHAM - $104,082 - JED GORLIN - $18,750 THE ORGANIZATION HAS A SECTION 457(F) PLAN FOR ITS CEO, CHRISTOPHER D. HILLYER, AND THE OTHER PARTICIPANTS LISTED BELOW. SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN BENEFITS ACCRUED BEFORE 2025 WERE VESTED AND PAID TO PARTICIPANTS IN 2025 AS FOLLOWS: - CHRISTOPHER HILLYER - $59,419 - BETSY JETT - $8,745 - JOSEPH MOHR - $20,911 - ANDREA CEFARELLI - $1,666 - BRUCE SACHAIS - $5,482 - JORDANA SCHWARTZ - $10,267 - DONNA STRAUSS - $4,984 - PATRICIA KILLEEN - $3,489 NEW PLAN BENEFITS FOR THE PARTICIPANTS IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN WERE ACCRUED IN 2025 AS FOLLOWS: - CHRISTOPHER HILLYER - $64,441 - BETSY JETT - $7,905 - JOSEPH MOHR - $24,109 - ANDREA CEFARELLI - $5,762 - BRUCE SACHAIS - $4,392 - DAVID BENCH - $15,433 - VAUGHN RATCHFORD - $5,788 - MEGHAN WOOD - $2,727 - RICHARD KIERNAN - $3,504 - SHILPI BANERJEE - $3,395 NEW PLAN BENEFITS ACCRUED IN 2025 ARE SUBJECT TO A THREE YEAR VESTING SCHEDULE WHICH IS A SUBSTANTIAL RISK OF FORFEITURE. PLAN BENEFIT AMOUNTS THAT BECOME VESTED TO PARTICIPANTS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (B)(III). NEW ACCRUALS OF PLAN BENEFITS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (C). PART I, LINE 7 UPON THE ORGANIZATION ACHIEVEING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CEO'S ANNUAL BONUS IS DISCRETIONARY DETERMINED BY THE BOARD AND BASED ON PERFORMANCE. A WESTCHESTER COUNTY LOCAL DEVELOPMENT FUND CORPORATION 455135576 95737TFT8 2024-01-24 51120737 RENOVATION OF 601 MIDLAND AVE RYE NY 0 0 0 A 51122081 1119393 50002688 2025 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 1 0 0 0 0 0 1 A 1 PART I, LINE A, COLUMN (E) AND PART II, LINE 3, COLUMN A: THE TOTAL PROCEEDS OF ISSUE PER PART II, LINE 3, COLUMN A EXCEEDS THE BOND ISSUE PRICE PER PART I, LINE A, COLUMN (E) BY $1,344. THE AMOUNT IS INTEREST PROCEEDS. JACKSON HILLYER SON OF CEO 63636 EMPLOYMENT 0 X 14 456768 COST X PROMO ITEMS 77 158885 COST 0 1 0 990 SCHEDULE M PART I COLUMN (B) THE NUMBER OF NON-CASH CONTRIBUTIONS RECEIVED IS REPORTED IN COLUMN (B). FORM 990, PART V, LINE 3B NEW YORK BLOOD CENTER INC. WILL REQUEST AN EXTENSION OF TIME TO FILE 2025 FORM 990-T. FORM 990, PART VI, SECTION A, LINE 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE COMPRISED OF THE CHAIR, VICE CHAIR AND THE CHAIR OF EACH OF THE STANDING COMMITTEES OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. FORM 990, PART VI, SECTION A, LINE 4 NEW YORK BLOOD CENTER'S BYLAWS WERE AMENDED TO ALLOW FOR EXTENSION OF THE TERMS OF THE SITTING CHAIR AND VICE CHAIR BY 2 YEARS. FORM 990, PART VI, SECTION B, LINE 11B FOLLOWING COMPLETION OF THE FINANCIAL STATEMENT AUDIT, THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM WITH THE INFORMATION PROVIDED BY MANAGEMENT, AND REVIEWED AND APPROVED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, AND ON AN AS-NEEDED BASIS, THE ORGANIZATION REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS, AND IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE ORGANIZATION MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S ANNUAL PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE ORGANIZATION USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE UPON REQUEST. NYBC VENTURES LLC 420 BOYLSTON STREET SUITE 501 BOSTON MA 02116 INVESTMENTS CONSISTENT WITH FUND INVESTMENT POLICY DE 22352590 NEW YORK BLOOD CENTER INC